Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protective Antibodies Against Influenza Proteins
Herbey Oswaldo Padilla-Quirarte, Delia Vanesa López-Guerrero, Lourdes Gutiérrez‐Xicoténcatl, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza
Sudha Chivukula, Timothy Plitnik, Timothy Tibbitts, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 86
Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels
Naif Khalaf Alharbi, Ibrahim Qasim, Abdulrahman Almasoud, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 81
Overview of Neutralizing Antibodies and Their Potential in COVID-19
José Javier Morales‐Núñez, José Francisco Muñoz‐Valle, Paola Carolina Torres-Hernández, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1376-1376
Open Access | Times Cited: 67
Intranasal vaccination with influenza HA/GO-PEI nanoparticles provides immune protection against homo- and heterologous strains
Chunhong Dong, Ye Wang, Gilbert X. Gonzalez, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 19
Open Access | Times Cited: 57
Immune Control of Avian Influenza Virus Infection and Its Vaccine Development
Piyush Dey, Akanksha Ahuja, Jaishal Panwar, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 593-593
Open Access | Times Cited: 25
Challenges of Making Effective Influenza Vaccines
Sigrid Gouma, Elizabeth M. Anderson, Scott E. Hensley
Annual Review of Virology (2020) Vol. 7, Iss. 1, pp. 495-512
Open Access | Times Cited: 54
Epitope profiling reveals binding signatures of SARS-CoV-2 immune response in natural infection and cross-reactivity with endemic human CoVs
Caitlin I. Stoddard, Jared Galloway, Helen Y. Chu, et al.
Cell Reports (2021) Vol. 35, Iss. 8, pp. 109164-109164
Open Access | Times Cited: 52
A spatial sequencing atlas of age-induced changes in the lung during influenza infection
Moujtaba Y. Kasmani, Paytsar Topchyan, Ashley K. Brown, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Induction of Enhanced Stem-directed Neutralizing Antibodies by HA2-16 Ferritin nanoparticles with H3 Influenza Virus Boost
Qingyu Wang, Jiaojiao Nie, Zejinxuan Liu, et al.
Nanoscale Advances (2025)
Open Access
Development and Validation of a Multiplex, Bead-based Assay to Detect Antibodies Directed Against SARS-CoV-2 Proteins
Robert A. Bray, Jar-How Lee, P. Brescia, et al.
Transplantation (2020) Vol. 105, Iss. 1, pp. 79-89
Open Access | Times Cited: 42
Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections
Hanaa Ahmed-Hassan, Brianna Sisson, Rajni Kant Shukla, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 41
Influenza A Virus Antibodies with Antibody-Dependent Cellular Cytotoxicity Function
Rongyuan Gao, Zizhang Sheng, Chithra Sreenivasan, et al.
Viruses (2020) Vol. 12, Iss. 3, pp. 276-276
Open Access | Times Cited: 34
Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses
Lucas Kerstetter, Stephen Buckley, Carly M. Bliss, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 29
The Anti-Viral and Anti-Inflammatory Properties of Edible Bird’s Nest in Influenza and Coronavirus Infections: From Pre-Clinical to Potential Clinical Application
Kien Hui Chua, Isa Naina Mohamed, Mohd Heikal Mohd Yunus, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 28
Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections
Pardis Mokhtary, Zeinab Pourhashem, Akram Abouei Mehrizi, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1861-1861
Open Access | Times Cited: 19
Influenza viral matrix 1 protein aggravates viral pathogenicity by inducing TLR4-mediated reactive oxygen species production and apoptotic cell death
Chang‐Ung Kim, Dahwan Lim, Young Sang Kim, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 11
Programming Multifaceted Pulmonary T Cell Immunity by Combination Adjuvants
Chandranaik B. Marinaik, Brock Kingstad-Bakke, Woo‐Jong Lee, et al.
Cell Reports Medicine (2020) Vol. 1, Iss. 6, pp. 100095-100095
Open Access | Times Cited: 28
Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases
Tharmala Tharmalingam, Xiaobing Han, Ashley Wozniak, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 18, Iss. 2
Open Access | Times Cited: 23
Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections
Ahmed Elkashif, Marwa Alhashimi, Ekramy E. Sayedahmed, et al.
Clinical & Translational Immunology (2021) Vol. 10, Iss. 10
Open Access | Times Cited: 23
Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses
Willemijn Rijnink, Daniel Stadlbauer, Eduard Puente‐Massaguer, et al.
Journal of Virology (2023) Vol. 97, Iss. 11
Open Access | Times Cited: 9
Multi-Epitope Peptide-Based and Vaccinia-Based Universal Influenza Vaccine Candidates Subjected to Clinical Trials
Syazwani Romeli, Sharifah Syed Hassan, Wei Boon Yap
Malaysian Journal of Medical Sciences (2020) Vol. 27, Iss. 2, pp. 10-20
Open Access | Times Cited: 25
mRNA-Based Vaccines and Mode of Action
Janina Gergen, Benjamin Petsch
Current topics in microbiology and immunology (2020), pp. 1-30
Closed Access | Times Cited: 24
Influenza Viruses: Harnessing the Crucial Role of the M2 Ion-Channel and Neuraminidase toward Inhibitor Design
Sphamandla E. Mtambo, Daniel G. Amoako, Anou M. Somboro, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 880-880
Open Access | Times Cited: 22
Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study
Joanna Waldock, Edmond J. Remarque, Lingyi Zheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Protective function and durability of mouse lymph node-resident memory CD8+ T cells
Scott M. Anthony, Natalija Budimir, Steven J. Moioffer, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top